Chris Wang

Chris Wang

Auto-generated profile, based on publicly available information

Chris Wang

Department of Computer Science, University of Missouri, Columbia, MO 65211, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020
Verified
Book Chapter
Closed access
PDF file
XXXin Xing
Xin Xing
GLGongbo Liang
Gongbo Liang
HBHunter Blanton
Hunter Blanton
MRMuhammad Usman Rafique
Muhammad Usman Rafique
CWChris Wang
Chris Wang
NJNathan Jacobs
Nathan Jacobs

16 January 2023 in Electronics
Verified
Journal Article
Open access
PDF file
XXXin Xing
Xin Xing
MRMuhammad Usman Rafique
Muhammad Usman Rafique
GLGongbo Liang
Gongbo Liang
HBHunter Blanton
Hunter Blanton
YZYu Zhang
Yu Zhang
ALAi-Ling Lin
Ai-Ling Lin
Three-dimensional convolutional neural networks (3D CNNs) have been widely applied to analyze Alzheimer’s disease (AD) brain images for a better understanding of the disease progress or predicting the conversion from cognitively impaired (CU) or mild cognitive impairment status. It is well-known that training 3D-CNN is computationally expensive and with the potential of overfitting due to the small sample size available in the medical imaging field. Here we proposed a novel 3D-2D approach by converting a 3D brain image to a 2D fused image using a Learnable Weighted Pooling (LWP) method to improve efficient training and maintain comparable model performance. By the 3D-to-2D conversion, the proposed model can easily forward the fused 2D image through a pre-trained 2D model while achieving better performance over different 3D and 2D baselines. In the implementation, we chose to use ResNet34 for feature extraction as it outperformed other 2D CNN backbones. We further showed that the weights of the slices are location-dependent and the model performance relies on the 3D-to-2D fusion view, with the best outcomes from the coronal view. With the new approach, we were able to reduce 75% of the training time and increase the accuracy to 0.88, compared with conventional 3D CNNs, for classifying amyloid-beta PET imaging from the AD patients from the CU participants using the publicly available Alzheimer’s Disease Neuroimaging Initiative dataset. The novel 3D-2D model may have profound implications for timely AD diagnosis in clinical settings in the future.

29 July 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
XXXin Xing
Xin Xing
GLGongbo Liang
Gongbo Liang
CWChris Wang
Chris Wang
NJNathan Jacobs
Nathan Jacobs
ALAi-Ling Lin
Ai-Ling Lin
The COVID-19 pandemic has underscored the urgent need for rapid and accurate diagnosis facilitated by artificial intelligence (AI), particularly in computer-aided diagnosis using medical imaging. However, this context presents two notable challenges: high diagnostic accuracy demand and limited availability of medical data for training AI models. To address these issues, we proposed the implementation of a Masked AutoEncoder (MAE), an innovative self-supervised learning approach, for classifying 2D Chest X-ray images. Our approach involved performing imaging reconstruction using a Vision Transformer (ViT) model as the feature encoder, paired with a custom-defined decoder. Additionally, we fine-tuned the pretrained ViT encoder using a labeled medical dataset, serving as the backbone. To evaluate our approach, we conducted a comparative analysis of three distinct training methods: training from scratch, transfer learning, and MAE-based training, all employing COVID-19 chest X-ray images. The results demonstrate that MAE-based training produces superior performance, achieving an accuracy of 0.985 and an AUC of 0.9957. We explored the mask ratio influence on MAE and found ratio = 0.4 shows the best performance. Furthermore, we illustrate that MAE exhibits remarkable efficiency when applied to labeled data, delivering comparable performance to utilizing only 30% of the original training dataset. Overall, our findings highlight the significant performance enhancement achieved by using MAE, particularly when working with limited datasets. This approach holds profound implications for future disease diagnosis, especially in scenarios where imaging information is scarce.

7 December 2013
Verified
Conference Paper
Open access
PDF file
Marco ZennaroMarco Zennaro
Marco Zennaro
EPErmanno Pietrosemoli
Ermanno Pietrosemoli
AAAndrés Arcia-Moret
Andrés Arcia-Moret
CMChomora Mikeka
Chomora Mikeka
JPJonathan Pinifolo
Jonathan Pinifolo
SSSteve Song
Steve Song
TV White Spaces (TVWS) technology and regulation has the potential to make connectivity both technically and economically feasible in rural Africa where affordable access remains a challenge. The superior propagation characteristics of TVWS technology make it particularly well suited to connecting remote communities. Evidence collected from our measurements in Malawi and Zambia suggest that most UHF spectrum is already available both in urban as well as in rural areas and could be used to provide Internet connectivity. In this paper we present the findings of a TVWS spectrum measurement initiative in Malawi and Zambia. We introduce an open hardware device that geo-tags spectrum measurements and saves the results on a micro SD card. The device can also be used to record the use of spectrum over long periods of time.

24 September 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
TNThong Minh Nguyen
Thong Minh Nguyen
CWCarter Woods
Carter Woods
JLJian Liu
Jian Liu
CWChris Wang
Chris Wang
ALAi-Ling Lin
Ai-Ling Lin
Jianlin ChengJianlin Cheng
Jianlin Cheng
The apolipoprotein E ε4 (APOE4) allele is the strongest genetic risk factor for late-onset Alzheimer’s disease (AD), the most common form of dementia. APOE4 carriers exhibit cerebrovascular and metabolic dysfunction, structural brain alterations, and gut microbiome changes decades before the onset of clinical symptoms. Better understanding of the early manifestation of these physiological changes is critical for development of timely AD interventions and risk reduction protocols. Multi-modal datasets encompassing a wide range of APOE ε4 and AD associated biomarkers provide a valuable opportunity to gain insight into the APOE4 phenotype; however, these datasets often present analytical challenges due to small sample sizes and high heterogeneity. Here, we propose a two-stage multimodal AI model (APOEFormer) that integrates blood metabolites, brain vascular and structural MRI, microbiome profiles, and other clinical and demographic data to predict APOE4 allele status. In the first stage, modality-specific encoders are used to generate initial representations of input data modalities, which are aligned in a shared latent space via self-supervised contrastive learning during pretraining. The contrastive learning objective encourages learning of informative and consistent representations across modalities through leveraging cross-modality relationships. In the second stage, the pretrained representations are used as inputs to a multimodal transformer that integrates information across modalities to predict a key AD-risk genetic variant (APOE4). Across 10 repeated experimental runs with different train–validation–test splits, APOEFormer predicts whether an individual carries an APOE4 allele with an average prediction accuracy of 75%, demonstrating robust performance under limited sample sizes. Post hoc perturbation analysis of the predictive model revealed valuable insights into the driving components of the APOE4 phenotype—including key blood biomarkers and brain regions strongly associated with APOE4.